New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive resp
World medicine December 11,2023
Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

Oral agent found to produce high response rate in patients with multiple myeloma when combined with steroid

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA new agent that subverts myeloma cells from within while also subjecting them to an immune system attack produced impressive resp
World medicine December 11,2023
Researchers identify marker that may predict whether lung cancer likely to spread

Researchers identify marker that may predict whether lung cancer likely to spread

byTulane UniversityTony Hu is the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine. Credit: Paula Burch-CelentanoNon-small cell lung cancer (NSC
World medicine December 11,2023
Researchers identify marker that may predict whether lung cancer likely to spread

Researchers identify marker that may predict whether lung cancer likely to spread

byTulane UniversityTony Hu is the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine. Credit: Paula Burch-CelentanoNon-small cell lung cancer (NSC
World medicine December 11,2023
No cancer risk found at nuclear bases so far, Air Force says

No cancer risk found at nuclear bases so far, Air Force says

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians, connect a re-entr
World medicine December 11,2023
No cancer risk found at nuclear bases so far, Air Force says

No cancer risk found at nuclear bases so far, Air Force says

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians, connect a re-entr
World medicine December 11,2023
Scientists identify first invasive case of rare mold in a cancer patient

Scientists identify first invasive case of rare mold in a cancer patient

by City of HopeCredit: CC0 Public DomainCity of Hope scientists have found a toxic fungus previously thought to not be infectious in the sinus tissues of a man with refractory acute lymphocytic leukem
World medicine December 11,2023
Scientists identify first invasive case of rare mold in a cancer patient

Scientists identify first invasive case of rare mold in a cancer patient

by City of HopeCredit: CC0 Public DomainCity of Hope scientists have found a toxic fungus previously thought to not be infectious in the sinus tissues of a man with refractory acute lymphocytic leukem
World medicine December 11,2023
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA new clinical tool developed by a team of researchers led by the Dana-Farber Cancer Institute pinpoints which Clonal hematopoiesis
World medicine December 11,2023
New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

New clinical tool for clonal hematopoiesis identifies patients at high risk for blood cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA new clinical tool developed by a team of researchers led by the Dana-Farber Cancer Institute pinpoints which Clonal hematopoiesis
World medicine December 11,2023
Breast cancer incidence rising for young women since 1935

Breast cancer incidence rising for young women since 1935

The incidence of breast cancer for women aged 25 to 39 years has been increasing since 1935 and seems not to be related to changes in parity over time, according to a study published online March 13 i
World medicine December 11,2023
Breast cancer incidence rising for young women since 1935

Breast cancer incidence rising for young women since 1935

The incidence of breast cancer for women aged 25 to 39 years has been increasing since 1935 and seems not to be related to changes in parity over time, according to a study published online March 13 i
World medicine December 11,2023
Under reporting of data on the outcomes among older adults in cancer clinical trials

Under reporting of data on the outcomes among older adults in cancer clinical trials

by Bill Bangert,University of CincinnatiKarlynn BrintzenhofeSzoc of the College of Allied Health Sciences shows her research paper to a class of graduate students in the School of Social Work. C
World medicine December 11,2023
Under reporting of data on the outcomes among older adults in cancer clinical trials

Under reporting of data on the outcomes among older adults in cancer clinical trials

by Bill Bangert,University of CincinnatiKarlynn BrintzenhofeSzoc of the College of Allied Health Sciences shows her research paper to a class of graduate students in the School of Social Work. C
World medicine December 11,2023
Functional outcomes similar across localized prostate cancer treatments

Functional outcomes similar across localized prostate cancer treatments

(HealthDay)—Most functional differences associated with contemporary management of localized prostate cancer attenuate by five years, according to a study published in the Jan. 14 issue of theJo
World medicine December 11,2023
Functional outcomes similar across localized prostate cancer treatments

Functional outcomes similar across localized prostate cancer treatments

(HealthDay)—Most functional differences associated with contemporary management of localized prostate cancer attenuate by five years, according to a study published in the Jan. 14 issue of theJo
World medicine December 11,2023
Outcomes steadily improve for multiple myeloma treated with ASCT

Outcomes steadily improve for multiple myeloma treated with ASCT

(HealthDay)—For patients with multiple myeloma (MM) treated with autologous stem cell transplantation (ASCT), long-term outcomes have improved steadily, according to a study published in the Jan. 28 i
World medicine December 11,2023
Outcomes steadily improve for multiple myeloma treated with ASCT

Outcomes steadily improve for multiple myeloma treated with ASCT

(HealthDay)—For patients with multiple myeloma (MM) treated with autologous stem cell transplantation (ASCT), long-term outcomes have improved steadily, according to a study published in the Jan. 28 i
World medicine December 11,2023
Study examines why colon cancer is more deadly in pediatric and young adult patients

Study examines why colon cancer is more deadly in pediatric and young adult patients

byAmerican College of SurgeonsColon Cancer in Patients Under 25 Years Old: A Different Disease? Credit: American College of SurgeonsColon cancer is more likely to be lethal in children and young
World medicine December 11,2023
Study examines why colon cancer is more deadly in pediatric and young adult patients

Study examines why colon cancer is more deadly in pediatric and young adult patients

byAmerican College of SurgeonsColon Cancer in Patients Under 25 Years Old: A Different Disease? Credit: American College of SurgeonsColon cancer is more likely to be lethal in children and young
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com